Status:
COMPLETED
Could the Cerebral Oximetry be a Good Technology to Measure Placental Oxygenation?
Lead Sponsor:
Maisonneuve-Rosemont Hospital
Collaborating Sponsors:
Université de Montréal
Conditions:
Placental Oxygenation
Eligibility:
FEMALE
18+ years
Brief Summary
To assess the potential of the cerebral oximeter to measure placental oxygenation
Detailed Description
There is general agreement among experts to recommend the use of phenylephrine as first line therapy for the treatment of arterial hypotension induced by spinal anaesthesia during caesarean delivery. ...
Eligibility Criteria
Inclusion
- healthy pregnant woman (ASA I or II)
- Term gestation ( \> 37 weeks)
- Normal pregnancy
- vaginal delivery
- obstetrical epidural in place
- anterior placenta
Exclusion
- patient refusal
- Any contraindication to neuraxial anesthesia
- cesarean section
- multiple gestation
- placentation abnormalities
- anormal placental perfusion
- Placental Abruption
Key Trial Info
Start Date :
April 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2013
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT01834599
Start Date
April 1 2013
End Date
July 1 2013
Last Update
April 15 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maisonneuve Rosemont Hospital
Montreal, Quebec, Canada, H1T 2M4